Bromperidol structure
|
Common Name | Bromperidol | ||
---|---|---|---|---|
CAS Number | 10457-90-6 | Molecular Weight | 420.31500 | |
Density | 1.366 g/cm3 | Boiling Point | 543.6ºC at 760 mmHg | |
Molecular Formula | C21H23BrFNO2 | Melting Point | 156-158ºC | |
MSDS | N/A | Flash Point | 282.6ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of BromperidolBromperidol is a butyrophenone derivative, is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia. |
Name | Bromperidol |
---|---|
Synonym | More Synonyms |
Description | Bromperidol is a butyrophenone derivative, is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia. |
---|---|
Related Catalog |
Density | 1.366 g/cm3 |
---|---|
Boiling Point | 543.6ºC at 760 mmHg |
Melting Point | 156-158ºC |
Molecular Formula | C21H23BrFNO2 |
Molecular Weight | 420.31500 |
Flash Point | 282.6ºC |
Exact Mass | 419.09000 |
PSA | 40.54000 |
LogP | 4.47260 |
Vapour Pressure | 1.19E-12mmHg at 25°C |
Index of Refraction | 1.59 |
Water Solubility | H2O: insoluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302 |
Precautionary Statements | P301 + P312 + P330 |
Hazard Codes | Xn |
Risk Phrases | 22 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | EU1180000 |
HS Code | 2933399090 |
~58% Bromperidol CAS#:10457-90-6 |
Literature: Vincent; Shambhu; Digenis Journal of medicinal chemistry, 1980 , vol. 23, # 1 p. 75 - 79 |
~78% Bromperidol CAS#:10457-90-6 |
Literature: Moerlein, Stephen M.; Stoecklin, Gerhard L. Journal of Medicinal Chemistry, 1985 , vol. 28, # 9 p. 1319 - 1324 |
Precursor 1 | |
---|---|
DownStream 1 | |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Simple and sensitive screening and quantitative determination of 88 psychoactive drugs and their metabolites in blood through LC–MS/MS: Application on postmortem samples
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 970 , 1-7, (2014) • The introduction has been modified. • More references have been added to the text. • Limitations of the method have been discussed more in detail. |
|
Sensitive determination of 4-(4-bromophenyl)-4-hydroxypiperidine, a metabolite of bromperidol, in rat plasma by HPLC with fluorescence detection after pre-column derivatization using 4-fluoro-7-nitro-2,1,3-benzoxadiazole.
Biol. Pharm. Bull. 29(12) , 2479-82, (2006) The purpose of this study was to determine the level of 4-(4-bromophenyl)-4-hydroxypiperidine (BPHP), a bromperidol (BRO) metabolite, in rat plasma by HPLC with fluorescence detection after pre-column... |
|
Folie à deux: double case-report of shared delusions with a fatal outcome.
Clin. Ter. 162(1) , 45-9, (2011) Treatment of shared delusional disorder (folie à deux) often involves separation and use of antipsychotic medication, with uncertain outcomes and potential risks.We report on two highly interdependent... |
MFCD00866670 |
4-(4-(4-Bromophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one |
EINECS 233-943-3 |
4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one |